164 related articles for article (PubMed ID: 7102416)
1. The pathophysiology of cerebral vasospasm, and pharmacological approaches to its management.
Towart R
Acta Neurochir (Wien); 1982; 63(1-4):253-8. PubMed ID: 7102416
[TBL] [Abstract][Full Text] [Related]
2. [Pathophysiology and principles of treatment of vasospasm].
Melon E
J Neuroradiol; 1999 Mar; 26(1 Suppl):S30-5. PubMed ID: 10363450
[TBL] [Abstract][Full Text] [Related]
3. The effects of HA compound calcium antagonists on delayed cerebral vasospasm in dogs.
Takayasu M; Suzuki Y; Shibuya M; Asano T; Kanamori M; Okada T; Kageyama N; Hidaka H
J Neurosurg; 1986 Jul; 65(1):80-5. PubMed ID: 3712031
[TBL] [Abstract][Full Text] [Related]
4. [Vascular and neuronal mechanisms of calcium antagonists. Significance in neurological therapy].
Govoni S; Trabucchi M; Battaini F; Magnoni MS; Paoletti R
Minerva Med; 1986 Jun; 77(24):1053-8. PubMed ID: 3725133
[TBL] [Abstract][Full Text] [Related]
5. Nimodipine: a new calcium antagonistic drug with a preferential cerebrovascular action.
Kazda S; Towart R
Acta Neurochir (Wien); 1982; 63(1-4):259-65. PubMed ID: 7102417
[TBL] [Abstract][Full Text] [Related]
6. [Cerebral vasospasm. The cerebral arterial spasm of subarachnoid hemorrhage--a new hemodynamic dimension].
Pendefunda L; Georgescu EM
Rev Med Chir Soc Med Nat Iasi; 1988; 92(4):649-54. PubMed ID: 3253916
[No Abstract] [Full Text] [Related]
7. Calcium blocking agents for treatment of cerebral vasospasm.
Peck S
J Neurosurg Nurs; 1983 Jun; 15(3):123-7. PubMed ID: 6553074
[No Abstract] [Full Text] [Related]
8. Calcium antagonists and vasospasm.
Meyer FB
Neurosurg Clin N Am; 1990 Apr; 1(2):367-76. PubMed ID: 2136149
[TBL] [Abstract][Full Text] [Related]
9. Current concepts of pathophysiology and management of cerebral vasospasm following aneurysmal subarachnoid hemorrhage.
Findlay JM; Macdonald RL; Weir BK
Cerebrovasc Brain Metab Rev; 1991; 3(4):336-61. PubMed ID: 1772740
[TBL] [Abstract][Full Text] [Related]
10. Cerebral vasospasm following aneurysmal subarachnoid hemorrhage.
Kassell NF; Sasaki T; Colohan AR; Nazar G
Stroke; 1985; 16(4):562-72. PubMed ID: 3895589
[TBL] [Abstract][Full Text] [Related]
11. Reversal of cerebral arterial spasm by intrathecal administration of a calcium antagonist (nimodipine).
Voldby B; Petersen OF; Buhl M; Jakobsen P; Ostergaard R
Acta Neurochir (Wien); 1984; 70(3-4):243-54. PubMed ID: 6546832
[TBL] [Abstract][Full Text] [Related]
12. The effects of an intracellular calcium antagonist HA 1077 on delayed cerebral vasospasm in dogs.
Shibuya M; Suzuki Y; Takayasu M; Asano T; Harada T; Ikegaki I; Satoh S; Hidaka H
Acta Neurochir (Wien); 1988; 90(1-2):53-9. PubMed ID: 3344625
[TBL] [Abstract][Full Text] [Related]
13. The pharmacology of cerebral vasospasm.
Cook DA
Pharmacology; 1984; 29(1):1-16. PubMed ID: 6379682
[TBL] [Abstract][Full Text] [Related]
14. [Cerebral vasospasm following subarachnoid hemorrhage. New aspects of diagnosis and therapy].
Voth D
Zentralbl Neurochir; 1987; 48(2):89-101. PubMed ID: 3314267
[TBL] [Abstract][Full Text] [Related]
15. Prevention and treatment of vasospasm.
Levati A; Solaini C; Boselli L
J Neurosurg Sci; 1998 Mar; 42(1 Suppl 1):27-31. PubMed ID: 9800599
[TBL] [Abstract][Full Text] [Related]
16. Treatment of vasospasm due to subarachnoid hemorrhage with calcium entry blockers.
Przuntek H; von Baumgarten F; Mertens HG
Eur Neurol; 1986; 25 Suppl 1():86-92. PubMed ID: 3530777
[TBL] [Abstract][Full Text] [Related]
17. [The pathogenesis and the preventive treatment of cerebral vasospasm following subarachnoid hemorrhage--especially clinical and pharmacological effect of Ca++ antagonist for vasospasm].
Nishizawa Y
Nihon Rinsho; 1993 Dec; 51 Suppl():389-96. PubMed ID: 8121018
[No Abstract] [Full Text] [Related]
18. Cerebral vasospasm.
Wilkins RH
Crit Rev Neurobiol; 1990; 6(1):51-77. PubMed ID: 2225095
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of the efficacy of intrathecal nimodipine in canine models of chronic cerebral vasospasm.
Gioia AE; White RP; Bakhtian B; Robertson JT
J Neurosurg; 1985 May; 62(5):721-8. PubMed ID: 3838768
[TBL] [Abstract][Full Text] [Related]
20. Cerebrovascular selectivity and vasospasmolytic action of the novel calcium antagonist (+/-)-(E)-1-(3-fluoro-6, 11-dihydrodibenz[b,e]oxepin-11-yl)-4-(3-phenyl-2-propenyl)-piperazine dimaleate in isolated cerebral arteries of the rabbit and dog.
Minato H; Hashizume M; Masuda Y; Fujitani B; Hosoki K
Arzneimittelforschung; 1997 Apr; 47(4):339-46. PubMed ID: 9150852
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
